These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 31709144)

  • 41. Histopathological findings in livers of patients with urea cycle disorders.
    Yaplito-Lee J; Chow CW; Boneh A
    Mol Genet Metab; 2013 Mar; 108(3):161-5. PubMed ID: 23403242
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Early allograft dysfunction in a pediatric liver allograft with an occult pathogenic mutation in the urea cycle.
    Rezvani M; Campbell KM; Prada CE; Peters AL
    Am J Transplant; 2023 May; 23(5):673-675. PubMed ID: 36870389
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Two novel CPS1 mutations in a case of carbamoyl phosphate synthetase 1 deficiency causing hyperammonemia and leukodystrophy.
    Chen X; Yuan L; Sun M; Liu Q; Wu Y
    J Clin Lab Anal; 2018 Jun; 32(5):e22375. PubMed ID: 29314318
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characterization and enzyme activity of argininosuccinate lyase/delta-crystallin of the embryonic duck lens.
    Piatigorsky J; Horwitz J
    Biochim Biophys Acta; 1996 Jul; 1295(2):158-64. PubMed ID: 8695641
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mutational analysis of duck delta 2 crystallin and the structure of an inactive mutant with bound substrate provide insight into the enzymatic mechanism of argininosuccinate lyase.
    Sampaleanu LM; Yu B; Howell PL
    J Biol Chem; 2002 Feb; 277(6):4166-75. PubMed ID: 11698398
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-term outcome of urea cycle disorders: Report from a nationwide study in Japan.
    Kido J; Matsumoto S; Häberle J; Nakajima Y; Wada Y; Mochizuki N; Murayama K; Lee T; Mochizuki H; Watanabe Y; Horikawa R; Kasahara M; Nakamura K
    J Inherit Metab Dis; 2021 Jul; 44(4):826-837. PubMed ID: 33840128
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Clinical and genetic analysis of two children suspected for argininosuccinic aciduria].
    Cheng W; Sun Y; Wang Y; Ma D; Jiang T
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2019 May; 36(5):443-446. PubMed ID: 31030429
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ornithine cycle in Nostoc PCC 73102: presence of an in vitro functional argininosuccinate lyase.
    Troshina O; Jansson E; Lindblad P
    FEMS Microbiol Lett; 1997 Jul; 152(1):75-81. PubMed ID: 9228773
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Activated microglia cells express argininosuccinate synthetase and argininosuccinate lyase in the rat brain after transient ischemia.
    Bizzoco E; Faussone-Pellegrini MS; Vannucchi MG
    Exp Neurol; 2007 Nov; 208(1):100-9. PubMed ID: 17900569
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Down-regulation of argininosuccinate lyase induces hepatoma cell apoptosis through activating Bax signaling pathway.
    Gong R; He L; Zhou H; Cheng S; Ren F; Chen J; Ren J
    Genes Dis; 2019 Sep; 6(3):296-303. PubMed ID: 32042869
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intragenic complementation at the argininosuccinate lyase locus: reconstruction of the active site.
    Howell PL; Turner MA; Christodoulou J; Walker DC; Craig HJ; Simard LR; Ploder L; McInnes RR
    J Inherit Metab Dis; 1998; 21 Suppl 1():72-85. PubMed ID: 9686346
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mutational analysis of amino acid residues involved in argininosuccinate lyase activity in duck delta II crystallin.
    Chakraborty AR; Davidson A; Howell PL
    Biochemistry; 1999 Feb; 38(8):2435-43. PubMed ID: 10029537
    [TBL] [Abstract][Full Text] [Related]  

  • 53. One Year Experience of Pheburane(®) (Sodium Phenylbutyrate) Treatment in a Patient with Argininosuccinate Lyase Deficiency.
    Uçar SK; Ozbaran B; Altinok YA; Kose M; Canda E; Kagnici M; Coker M
    JIMD Rep; 2015; 19():31-3. PubMed ID: 25665834
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reduced expression of argininosuccinate lyase is closely associated with postresectional survival in hepatocellular carcinoma: an immunohistochemistry study of 61 cases.
    Yang H; Zhai G; Ji X; Su J; Lin M
    Appl Immunohistochem Mol Morphol; 2012 Dec; 20(6):602-6. PubMed ID: 22531684
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Genetic analysis of ASS1, ASL and SLC25A13 in citrullinemia patients].
    Wen P; Chen Z; Wang G; Liu X; Chen L; Chen S; Wan L; Cui D; Shang Y; Li C
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2014 Jun; 31(3):268-71. PubMed ID: 24927999
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Diagnosis and treatment of urea cycle disorder in Japan.
    Nakamura K; Kido J; Mitsubuchi H; Endo F
    Pediatr Int; 2014 Aug; 56(4):506-9. PubMed ID: 25039902
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Recovery of argininosuccinate lyase activity in duck delta1 crystallin.
    Tsai M; Koo J; Howell PL
    Biochemistry; 2005 Jun; 44(25):9034-44. PubMed ID: 15966727
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Novel Neonatal Variants of the Carbamoyl Phosphate Synthetase 1 Deficiency: Two Case Reports and Review of Literature.
    Yan B; Wang C; Zhang K; Zhang H; Gao M; Lv Y; Li X; Liu Y; Gai Z
    Front Genet; 2019; 10():718. PubMed ID: 31507628
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Argininosuccinate lyase: a new autoantigen in liver disease.
    Pelli N; Fensom AH; Slade C; Boa F; Mieli-Vergani G; Vergani D
    Clin Exp Immunol; 1998 Dec; 114(3):455-61. PubMed ID: 9844057
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Attenuation of argininosuccinate lyase inhibits cancer growth via cyclin A2 and nitric oxide.
    Huang HL; Hsu HP; Shieh SC; Chang YS; Chen WC; Cho CY; Teng CF; Su IJ; Hung WC; Lai MD
    Mol Cancer Ther; 2013 Nov; 12(11):2505-16. PubMed ID: 23979921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.